Novartis Gene Therapies

Novartis Gene Therapies, based in Bannockburn, Illinois, is a biotechnology company focused on developing gene therapies for rare genetic diseases. Employing around 966 people, the company is a subsidiary of Novartis Pharmaceuticals. Novartis Gene Therapies specializes in turning promising gene therapies into reality, with a particular focus on spinal muscular atrophy (SMA). The company utilizes advanced technology to create innovative treatments that aim to significantly improve the lives of patients with these debilitating conditions. The company is known for its commitment to research and development, constantly pushing the boundaries of scientific innovation to bring new and effective treatments to patients in need. For inquiries or further information, please contact Novartis Gene Therapies at 2275 Half Day Road, Suite 200, Bannockburn, IL 60015. You can reach them via email at [email protected], or by phone at 847.572.8280 (office) or 844.428.3947 (toll-free).